TUDCA-ALS-1166706 Demographic and clinical description of the study population | ERD

Summary

This report will include study population data on demographic and clinical aspects

More information & hyperlinks

Web resources:

https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e506972fc3&appId=PPGMS

Search

Associated projects

TUDCA-ALS - Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)

Organisations

Not specified